<DOC>
	<DOCNO>NCT01760499</DOCNO>
	<brief_summary>The main purpose study find PV-10 work melanoma tumor . Researchers also want find change body 's immune cell ( cell fight infection illness ) PV-10 give , inside melanoma tumor circulate blood .</brief_summary>
	<brief_title>Detection Immune Cell Infiltration Into Melanomas Treated PV-10 , Feasibility Study</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>Patients diagnose metastatic melanoma , suspect metastatic melanoma subsequently proven metastatic melanoma biopsy Patients plan undergo surgical resection least two foci palpable cutaneous subcutaneous metastatic melanoma , either palliative therapeutic intent consent preoperative core biopsy least two resectable lesion prior surgery Patients give informed consent participate study Patients decline consent study Patients previously receive PV10 therapy Patients suspect metastatic melanoma proven preoperative biopsy replace count accrual goal Patients undergo surgical resection least two metastatic melanoma lesion include PV10 treat lesion replace count accrual goal . Patients whose melanoma lesion contiguous , encompass infiltrate major blood vessel Patients allergy shellfish due report crossreactivity PV10 Patients previous sensitivity iodide Patients treatable target lesion portion body head neck Concurrent Intercurrent Illness : Patients condition impair wound healing ( uncontrolled diabetes mellitus immunosuppressive steroid dependence ) opinion PI unsafe patient undergo intralesional PV10 treatment Patients severe peripheral vascular disease ( i.e. , claudication occur less 200 meter walk , rest pain , ischemic ulceration gangrene ) Patients significant concurrent intercurrent illness , psychiatric disorder , alcohol chemical dependence would , opinion principal investigator ( PI ) , compromise safety compliance interfere interpretation study result Patients uncontrolled thyroid disease , goiter , partial thyroidectomy , previous radioiodine surgicallytreated Graves ' hyperthyroidism cystic fibrosis Patients clinically significant cardiovascular , cerebrovascular , peripheral vascular , renal , gastrointestinal , pulmonary , immunological , endocrine , bone marrow central nervous system disorder require hospitalization within past 12 month Pregnancy Female patient positive pregnancy test lactating . Fertile patient agree use effective contraception ( i.e. , oral contraceptive , intrauterine device , double barrier method condom diaphragms , abstinence equivalent measure ) begin time sign consent surgery . Patients dependent upon concomitant medication predispose photosensitivity stop medication ( ) period start 24 hour prior end 24 hour PV10 treatment exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>skin</keyword>
	<keyword>metastatic</keyword>
</DOC>